http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113642386-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec4bcdaa73ebd0f1e6cd2c2353e11db5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bff0c090d26700ae6eb0c02de11fc29f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30096 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06K9-00 |
| filingDate | 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b09983d3b42e284f5df8ce9771762867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71f7a69f30bf31af5dfa4d5c71b44032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_860657e999b702bec1d7b085bc6de0c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72d1468c3423e9d0491ca0b131db4446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56258f2fb2014cacbd04579898c30773 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58b07552d91be4a36189cfc8d6e8ded9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5afda9b57e0c32ca442bf337028056e1 |
| publicationDate | 2021-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113642386-A |
| titleOfInvention | Method, device, equipment and medium for evaluating nasopharyngeal carcinoma treatment effect based on deep learning |
| abstract | The invention discloses a method for evaluating the treatment effect of nasopharyngeal carcinoma based on deep learning, which comprises the following steps: the first nasopharyngeal carcinoma cell percentage before nasopharyngeal carcinoma tissue treatment and the second nasopharyngeal carcinoma cell percentage after nasopharyngeal carcinoma tissue treatment are respectively obtained through the first recognition model, and consistency of front and back recognition standards of the nasopharyngeal carcinoma cells is ensured on the basis of the same recognition model. In addition, a method for evaluating the treatment response of the paraneoplastic tissues is also added, and the method comprises the step of obtaining the percentage of the actual pathological area after the paraneoplastic tissues are treated through a second identification model. Then, a first rating is determined according to the percentage of the first nasopharyngeal carcinoma cells and the percentage of the second nasopharyngeal carcinoma cells, a second rating is determined according to the percentage of the actual pathological area, and finally, the first rating and the second rating are summarized to form comprehensive evaluation. The whole scheme is rated and evaluated based on data obtained by a trained recognition model, and consistency, accuracy and objectivity of pathology evaluation are guaranteed. In addition, a nasopharyngeal carcinoma treatment effect evaluation device, equipment and a storage medium are also provided. |
| priorityDate | 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450235101 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86598188 |
Total number of triples: 23.